Advances in non-invasive neuromodulation (NM) have enabled practitioners to modulate neural activity safely, offering a promising approach to treating neuropsychiatric and neurological conditions. This study aimed to analyze the training profiles of NM practitioners and assess their perceptions of NM’s clinical efficacy, safety, and patient satisfaction. An online survey was conducted among 117 practitioners in various healthcare fields, using the Clinical Global Impression (CGI) scale to gauge outcomes. The findings indicate that 99.13% of practitioners perceive NM as effective, with high rates of patient improvement in quality of life and symptom management. The study underscores the importance of standardized NM training protocols to enhance therapeutic outcomes.
This study aimed to assess the immediate effects of transcutaneous spinal direct current stimulation (tsDCS) on pain outcomes, measured using the visual analog scale (VAS) and pressure pain thresholds in a cohort of 55 participants experiencing chronic pain using a controlled, randomized trial with 55 participants allocated into 2 groups: 2 mA and 0.5 mA of tsDCS for 20 min. Anodal stimulation was applied on the 12th thoracic vertebra, with the cathode positioned on the 7th cervical vertebra. Pain outcomes were assessed before and post intervention using the VAS and pressure algometry. Between- and within-group differences, along with chi-square tests, were used to determine the differences and responsiveness. Significance was established at p < 0.05. Findings showed significant temporal effects for both VAS (p < 0.001) and pressure algometry (p = 0.04). However, no between-group differences were noted for the time × group factor for VAS (p = 0.46) and pressure algometry (p = 0.78). No significant between-group differences were observed for the responsiveness analysis. The results indicate that a single 20-min session of 2 and 0.5 mA tsDCS improves pain scores for both intensities equally. However, there were no statistically significant between-group differences in pain perception or pressure pain threshold.
Background: Temporomandibular disorders (TMD) are associated with altered masticatory muscle function and pain. Although electromyographic parameters have been extensively studied, the rate of force development (RFD) remains an underexplored biomarker in this context. Objective: Analyze the RFD differences in women diagnosed with and without TMD. As a secondary outcome, the masseter and temporalis muscle pre-activation values were between-group compared based on the biting force onset. Additionally, neuromuscular efficiency analysis was also performed. Methods: A retrospective analysis of 62 medical records (41 with TMD, 21 controls) was conducted. Electromyographic activity and bite force were measured during three 5-second maximal biting tasks using synchronized surface electromyography (sEMG) and a laboratory-grade load cell. RFD was computed from force-time curves. Muscle preactivation was assessed based on sEMG activity immediately preceding contraction onset. Results: The TMD group showed a significantly smaller RFD (mean = 85.5 N/s) compared to controls (mean = 109.0 N/s; p = 0.03; Cohen’s d = 0.5). No significant differences were found in neuromuscular efficiency and preactivation or post-activation levels of the masseter and temporalis muscles between groups. Conclusions: RFD distinguishes women with TMD from healthy controls and may represent a sensitive biomechanical marker of neuromuscular adaptation in TMD, although confirmatory studies are needed. The absence of neuromuscular efficiency and preactivation differences suggests compensatory neuromuscular mechanisms. Further prospective studies are needed to validate these findings and explore clinical applications.
This study aimed to assess the immediate effects of transcutaneous spinal direct current stimulation (tsDCS) on pain outcomes, measured by the visual analog scale (VAS) and pressure pain thresholds in a cohort of 55 participants experiencing chronic pain. A controlled, randomized trial with 55 participants allocated into 2 groups: 2 mA and 0.5 mA of tsDCS for 20 minutes. Anodal stimulation was applied on the 12th thoracic vertebra, and cathodal stimulation on the 7th cervical vertebra. Pain outcomes were assessed before and post-intervention using the VAS and pressure algometry. Between and within-group differences, along with chi-square tests were used to determine the differences and responsiveness. Significance was established at p < 0.05. Findings showed significant temporal effect for both VAS (p < 0.001) and pressure algometry (p = 0.04). However, no between-group differences were noted in the time*group factor for VAS (p = 0.466) and pressure algometry (p = 0.78). No significant between-group differences were observed for the responsiveness analysis. The results indicate that a single 20-minute session of 2 and 0.5 mA tsDCS improves pain scores for both intensities equally. However, there were no statistically significant between-group differences in pain perception or pressure pain threshold.
Advances in non-invasive neuromodulation (NM) have enabled practitioners to modulate neural activity safely, offering a promising approach to treating neuropsychiatric and neurological conditions. This study aimed to analyze the training profiles of NM practitioners and assess their perceptions of NM’s clinical efficacy, safety, and patient satisfaction. An online survey was conducted among 117 practitioners in various healthcare fields, using the Clinical Global Impression (CGI) scale to gauge outcomes. Findings indicate that 99.13% of practitioners perceive NM as effective, with high rates of patient improvement in quality of life and symptom management. The study underscores the importance of standardized NM training protocols to enhance therapeutic outcomes.
Objective: to assess the combined effects of aVNS, TENS, and transmeatal photobiomodulation on tinnitus perception and discomfort. Methods: This was a retrospective quasi-experimental study using medical records of 120 patients with chronic somatosensory tinnitus treated at a specialized health center. Interventions included auricular vagus nerve stimulation (aVNS), cervical transcutaneous electrical nerve stimulation (TENS), and transmeatal photobiomodulation with laser. The Visual Analogue Scale (VAS) scores for tinnitus loudness and discomfort and Tinnitus Handicap Inventory (THI) scores were assessed pre- and post-intervention. Results: Non-parametric and frequency tests were used to compare outcomes, and effect sizes (ES) were calculated. Significant reductions were observed in VAS loudness (p = 0.001; ES = 2.01) and discomfort (p = 0.001; ES = 2.23), as well as THI scores (p = 0.001; ES = 2.28). The severity classifications of tinnitus, based on VAS and THI scores, also improved significantly. The effect sizes were very large for all variables, suggesting a synergistic beneficial effect from combined interventions. Conclusions: The combination of aVNS, TENS, and transmeatal photobiomodulation seems to be an effective therapeutic strategy for reducing tinnitus perception, discomfort, and self-perceived handicap. While these findings highlight the potential of this multimodal approach, further randomized controlled trials are necessary to confirm its efficacy and elucidate the underlying mechanisms.